Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Sep 27, 2024 11:55AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hey Narmac
i agree 100% with your statements
Anyone want to forward to the both Don McCaffrey and the BOD all the Biotech IPO and deals you linked to say what bullshit that the market right now is so difficult to get a BP deal